Monthly Archives: June 2023

Top 10 cities with the most lead pipes

Note: This blog has been updated and adapted. For the most up-to-date information, please visit our new page, Top 10 Cities with the Most Lead Pipes.

 

Roya Alkafaji, Manager, Healthy Communities and Tom Neltner, Senior Director, Safer Chemicals Initiative

EDF identified 10 cities in the U.S. with the most lead service lines (LSLs) based on numbers reported in 2021.[1] These cities collectively have over one million LSLs, representing 12% of the 9.2 million EPA estimates are in the country.

Below we rank each city from most LSLs to fewest, and briefly describe the progress each city has made toward LSL replacement. Some have robust programs, while others have yet to start addressing the problem.

The List

1. Chicago, IL

Chicago Department of Water Management reported 387,095 LSLs in 2021, more than twice as many as the next city on this list. Three-quarters of its service lines are LSLs, and virtually all the rest are of unknown material. City ordinance actually mandated that LSLs be installed until the federal government banned them in 1986.

Decades later, Chicago is struggling to pull itself out of a deep hole relative to most other large cities that took earlier action against lead pipes. Chicago has a small LSL replacement program but applied for a $336 million loan from EPA in 2020[2] and $8 million in state revolving funds (SRF) from Illinois EPA in 2023 to accelerate the effort.

2. Cleveland, OH

Cleveland Water reported 185,409 LSLs in 2021, about 43% of all its service lines.

The utility has a small LSL replacement program but is seeking more than $63 million in federal infrastructure funding from Ohio EPA in 2023 to accelerate the effort.

3. New York, NY

New York City reported 137,542 LSLs in 2021 and an additional 230,870 lines that are of unknown material. About 43% of the city’s service lines are lead or of unknown material.

It has a small LSL replacement program and is seeking more than $58 million in federal infrastructure funding from New York State DEP in 2023 to accelerate the effort.

Read More »

Posted in Drinking water, Lead / Tagged , , , , | Authors: , / Comments are closed

Representatives Call For FDA Public Hearing on Phthalates

By. Joanna Slaney, Senior Director, Federal Affairs, and Maricel Maffini, PhD, Consultant

U.S. Capitol dome framed by trees

Source: A. Paige Baker, ShutterSights.com©

What Happened?

On May 19, Reps. Katie Porter, Steve Cohen, Nanette Diaz Barragán, Earl Blumenauer, and Raúl Grijalva issued a letter [PDF, 300KB] to FDA Commissioner Robert Califf calling on FDA to “act expeditiously to protect the public from the health risks posed by phthalates in food and food packaging.”

They asked the FDA to hold a public hearing on ortho-phthalates (phthalates), chemicals associated with disruptions to the development of the male reproductive system and neurodevelopment, among other health effects.

Why It Matters

In 2021, Reps. Porter and Lieu led a letter with 12 colleagues urging FDA to take action on phthalates in food and cosmetics. That letter, in part, called on FDA to take action on a 2016 petition filed by EDF and allied environmental health organizations asking FDA to revoke its approval for all uses of phthalates in food packaging and processing equipment.

In May 2022, after the petitioners sued, FDA denied the petition. The petitioners formally objected to the decision and requested a public hearing pursuant to FDA’s regulations. The agency has not provided any timeline for acting on the objections.

Request for a Public Hearing

The Representatives stated in the letter submitted last month that  FDA’s decision denying the petition was flawed. “[W]e are deeply concerned about the denial, which was made without deciding whether the remaining approved uses of phthalates in food and food packaging are safe.” (Emphasis original)

They reminded Commissioner Califf of his recent statement that chemical safety is a “really, really important area for the future – for humankind, really – and where science is evolving rapidly,” urging FDA to hold a public hearing on two areas of concern:

  • The agency’s failure to evaluate the safety of phthalates as it was legally required to do before denying the 2016 petition. The letter stated, “failing to evaluate the safety of phthalates is an abdication of the FDA’s continuing obligation to oversee the safety of the food supply.”
  • FDA’s failure to address new toxicity information that raises significant questions about the safety of phthalates. Phthalates are associated with numerous health issues, including reproductive and developmental toxicity, endocrine disruption, immune toxicity, and epigenetic alterations. The letter stated, “the denial of the petition fails to acknowledge, let alone analyze, the dozens of peer-reviewed studies that underscore the toxicity of the phthalates that remain approved for food contact use.”

Next Steps

EDF and our allies will continue to press FDA to hold a public hearing on the safety of phthalates used in food packaging and processing equipment.

Go Deeper

EDF blogs on phthalates

Posted in Congress, Developmental toxicity, Endocrine disruptors, FDA, Food, Food packaging, Health science, Phthalates, Public health, Public hearing, Regulation, Reproductive toxicity / Tagged , , , , , | Authors: , / Comments are closed